SI1583525T1 - Uporaba kombinacije snovi porfirinske sinteze, salicilatov in antioksidantov pri fototerapiji koĹľnih in/ali sklepnih obolenj - Google Patents

Uporaba kombinacije snovi porfirinske sinteze, salicilatov in antioksidantov pri fototerapiji koĹľnih in/ali sklepnih obolenj

Info

Publication number
SI1583525T1
SI1583525T1 SI200331911T SI200331911T SI1583525T1 SI 1583525 T1 SI1583525 T1 SI 1583525T1 SI 200331911 T SI200331911 T SI 200331911T SI 200331911 T SI200331911 T SI 200331911T SI 1583525 T1 SI1583525 T1 SI 1583525T1
Authority
SI
Slovenia
Prior art keywords
phototherapy
salicylates
antioxidants
combination
porphyrin synthesis
Prior art date
Application number
SI200331911T
Other languages
English (en)
Slovenian (sl)
Inventor
Gerhard Saalmann
Peter Saalmann
Hagen Tronnier
Original Assignee
Medlight Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medlight Gmbh filed Critical Medlight Gmbh
Publication of SI1583525T1 publication Critical patent/SI1583525T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200331911T 2003-01-17 2003-12-23 Uporaba kombinacije snovi porfirinske sinteze, salicilatov in antioksidantov pri fototerapiji koĹľnih in/ali sklepnih obolenj SI1583525T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10301917A DE10301917B4 (de) 2003-01-17 2003-01-17 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
PCT/DE2003/004254 WO2004064827A1 (de) 2003-01-17 2003-12-23 Verwendung von substanzen der porphyrinsynthese für die anwendung in der phototherapie sowie zur behandlung von haut- und/oder gelenkerkrankungen
EP03815354A EP1583525B1 (de) 2003-01-17 2003-12-23 Verwendung einer kombination von substanzen der porphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen

Publications (1)

Publication Number Publication Date
SI1583525T1 true SI1583525T1 (sl) 2011-01-31

Family

ID=32602752

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331911T SI1583525T1 (sl) 2003-01-17 2003-12-23 Uporaba kombinacije snovi porfirinske sinteze, salicilatov in antioksidantov pri fototerapiji koĹľnih in/ali sklepnih obolenj

Country Status (13)

Country Link
US (1) US20070099878A1 (enExample)
EP (1) EP1583525B1 (enExample)
JP (1) JP2006514072A (enExample)
AT (1) ATE479431T1 (enExample)
AU (1) AU2003300499A1 (enExample)
CY (1) CY1110957T1 (enExample)
DE (2) DE10301917B4 (enExample)
DK (1) DK1583525T3 (enExample)
ES (1) ES2351971T3 (enExample)
PT (1) PT1583525E (enExample)
RU (1) RU2336078C2 (enExample)
SI (1) SI1583525T1 (enExample)
WO (1) WO2004064827A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
DE102011117364A1 (de) * 2011-10-29 2013-05-02 Merck Patent Gmbh Hautaufheller in der Phototherapie
DE202013003573U1 (de) 2013-04-16 2013-06-04 Gerhard Saalmann Ganzkörper-Belichtungseinheit
RU2712806C1 (ru) * 2019-05-20 2020-01-31 Федеральное государственное бюджетное учреждение "Государственный научный центр лазерной медицины имени О.К. Скобелкина Федерального медико-биологического агентства" Способ лечения больных перипротезной инфекцией после эндопротезирования сустава

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
DE4440112A1 (de) * 1994-11-11 1996-05-15 Jan H Dr Wilkens Bestrahlungsanordnung zur Behandlung von Hauterkrankungen
US5530157A (en) * 1995-02-16 1996-06-25 Scios Nova Inc. Anti-inflammatory benzoic acid derivatives
KR100444007B1 (ko) * 1995-03-10 2004-12-03 포토큐레 에이에스에이 광화학치료또는진단에사용하기위한5-아미노레불린산의에스테르
EP0959879B1 (en) * 1996-10-10 2004-05-06 The General Hospital Corporation Photodynamic therapy for the treatment of osteoarthritis
RU2145247C1 (ru) * 1998-04-10 2000-02-10 Жаров Владимир Павлович Фотоматричное терапевтическое устройство для лечения протяженных патологий
DE69940738D1 (de) * 1998-07-09 2009-05-28 Curelight Medical Ltd Vorrichtung und verfahren zur wirkungsvollen hochenergetischen photodynamischen therapie von akne vulgaris und seborrhoe
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
ES2243549T3 (es) * 2000-09-08 2005-12-01 Vivier Canada Inc. Soluciones de acido ascorbico estabilizadas.
DE10063076A1 (de) 2000-12-18 2002-06-27 Medac Klinische Spezialpraep Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe
CA2450370A1 (en) * 2001-06-11 2002-12-19 Jody Mesaros Accelerators for increasing the rate of formation of free radicals and reactive oxygen species
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders

Also Published As

Publication number Publication date
US20070099878A1 (en) 2007-05-03
EP1583525A1 (de) 2005-10-12
ES2351971T3 (es) 2011-02-14
DE50313052D1 (de) 2010-10-14
DK1583525T3 (da) 2011-01-03
AU2003300499A1 (en) 2004-08-13
CY1110957T1 (el) 2015-06-11
RU2005127035A (ru) 2006-01-27
PT1583525E (pt) 2010-12-07
DE10301917B4 (de) 2007-02-01
ATE479431T1 (de) 2010-09-15
WO2004064827A1 (de) 2004-08-05
JP2006514072A (ja) 2006-04-27
DE10301917A1 (de) 2004-07-29
RU2336078C2 (ru) 2008-10-20
EP1583525B1 (de) 2010-09-01

Similar Documents

Publication Publication Date Title
US8574177B2 (en) Phototherapy and massage apparatus for treating medical conditions in body cavities
Kessel Photodynamic therapy: from the beginning
GB2444855B8 (en) Apparatus and method for photodynamic diagnosis and therapy of skin diseases and light source systemthereof
IL189019A0 (en) Pdt (photodynamic therapy) treatment method for cellulites and cosmetic use
AU2003248747A1 (en) Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
GB0720738D0 (en) Devices and kits for phototherapy and photodynamic therapy treatment of body cavities
AU2004207813A8 (en) Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles
DK1742644T3 (da) Terapeutisk sammensætning indeholdende mindst et pyrrolbenzodiazepin-derivat og fludarabin
CY1107963T1 (el) Μεσο-υποκαθιστοyμενες πορφυρiνες
WO2004075985A3 (en) Cosmetic or therapeutic methods and apparatus
DE602004023183D1 (de) Gegen antikörper gerichtete photodynamische therapie
CY1115407T1 (el) Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων
KR101663346B1 (ko) 안면유도장치 및 안면유도방법
WO2007100839A3 (en) Method and apparatus for application of light to tissue
SI1583525T1 (sl) Uporaba kombinacije snovi porfirinske sinteze, salicilatov in antioksidantov pri fototerapiji koĹľnih in/ali sklepnih obolenj
WO2003028629A3 (en) Chlorin photosensitizing agents for use in photodynamic therapy
DE60234930D1 (en) Farbstoff-sulfenate für die duale phototherapie
EP2226318A3 (en) Dye-Azide compounds for dual photherapy
EP2437847A4 (en) CANCER TREATMENT THROUGH PHOTODYNAMIC THERAPY
MXPA04007443A (es) Nuevos compuestos de porfirina-platino solubles en agua con alta selectividad tumoral y su uso para el tratamiento de enfermedades tumorales benignas y malignas.
WO2006047414A3 (en) Chemiluminescent phototherapy device
GB0721437D0 (en) Light delivery apparatus using a combination of different lamps for use in photodynamic therapy of tumours and other diseases
Edge et al. Biophotonic Therapy Induced Photobiomodulation
CA2775529C (en) High powered light emitting diode photobiology device
RU2006101260A (ru) Способ фотодинамической терапии онкологических заболеваний